Nelly Viseux

VP Cell Therapies Development, Manufacturing Supply & Quality, Regeneron Pharmaceuticals

Nelly Viseux is listed as VP Cell Therapies Development, Manufacturing Supply & Quality, Regeneron Pharmaceuticals. Nelly is scheduled to speak at Advanced Therapies Week 2027 on 19 January 2027.

Compiled from published conference agendas; not yet confirmed by Nelly. Is this you? Claim this profile.

Upcoming

Advanced Therapies Week 2027 19 January 2027 – 21 January 2027

• Session 1: Which process and analytical tools have the requisite flexibility, scalability, and cost-effectiveness to enable rapid clinical translation while laying the groundwork for later development and commercialisation? Part 1 Speaker · 19 January 2027
• Spotlight Speaker · 19 January 2027
• Pharma roundtable Speaker · 20 January 2027
• Plenary: Plotting a course to sustainable future success for the cell & gene therapy industry Speaker · 20 January 2027

Spoke alongside

People who have shared a session with Nelly at events on B2DB.

• Cédric Cleyrat Executive Director, Head of Cell Therapy BioEngineering & Technology Innovation · Bristol Myers Squibb 2 shared sessions
• Sven Kili Partner · Saisei Ventures 1 shared session
• Gina Jiang Managing Director · Hong Kong Institute of Biotechnology 1 shared session
• Meena Narayanan Senior Scientist - Process Analytics · Genentech 1 shared session
• Ohad Karnieli Adva Biotechnology 1 shared session
• Peter He Co-Founder & Chief Scientific Officer · OriCell Therapeutics 1 shared session
• Samar Mohanty President & CSO · Nanoscope Therapeutics 1 shared session
• Steven Oh Director, Office of Cellular Therapy and Human Tissue, Office of Therapeutic Products, CBER · US Food & Drug Administration 1 shared session
• Vasily Medvedev Chief Technology Officer · VVMF 1 shared session
• Yoshiaki Maruyama Director, Office of Cellular and Tissue-based Products · Pharmaceuticals and Medical Devices Agency (PMDA), Japan 1 shared session